Back to today’s briefing

Story perspectives

Clopidogrel Beats Aspirin in Heart Attack Prevention

4/1/2025

47 11

Summary

Story summary

Korean researchers have unveiled groundbreaking findings: clopidogrel outshines aspirin in preventing recurrent coronary heart attacks post-PCI. In a comprehensive study of 5,506 patients, clopidogrel slashed the risk of death, heart attacks, and strokes by 29%, all while keeping bleeding risks at bay. This pivotal research was featured in The Lancet and showcased at the ACC Annual Scientific Sessions.

1 of 1

Story summary

Korean researchers have unveiled groundbreaking findings: clopidogrel outshines aspirin in preventing recurrent coronary heart attacks post-PCI. In a comprehensive study of 5,506 patients, clopidogrel slashed the risk of death, heart attacks, and strokes by 29%, all while keeping bleeding risks at bay. This pivotal research was featured in The Lancet and showcased at the ACC Annual Scientific Sessions.